Correlation Between Pharmaceuticals Ultrasector and Short Precious

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Short Precious at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Short Precious into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Short Precious Metals, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Short Precious and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Short Precious. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Short Precious.

Diversification Opportunities for Pharmaceuticals Ultrasector and Short Precious

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pharmaceuticals and Short is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Short Precious Metals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Short Precious Metals and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Short Precious. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Short Precious Metals has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Short Precious go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Short Precious

Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 0.86 times more return on investment than Short Precious. However, Pharmaceuticals Ultrasector Profund is 1.17 times less risky than Short Precious. It trades about 0.12 of its potential returns per unit of risk. Short Precious Metals is currently generating about -0.01 per unit of risk. If you would invest  1,668  in Pharmaceuticals Ultrasector Profund on April 21, 2025 and sell it today you would earn a total of  248.00  from holding Pharmaceuticals Ultrasector Profund or generate 14.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pharmaceuticals Ultrasector Pr  vs.  Short Precious Metals

 Performance 
       Timeline  
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Pharmaceuticals Ultrasector showed solid returns over the last few months and may actually be approaching a breakup point.
Short Precious Metals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Short Precious Metals has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Short Precious is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pharmaceuticals Ultrasector and Short Precious Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmaceuticals Ultrasector and Short Precious

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Short Precious positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Short Precious can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Short Precious will offset losses from the drop in Short Precious' long position.
The idea behind Pharmaceuticals Ultrasector Profund and Short Precious Metals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios